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background: Primary percutaneous coronary intervention 
(primary PCI) is the preferred reperfusion method in patients 
with ST-segment elevation myocardial infarction (STEMI). 
Manual aspiration thrombectomy has been increasingly used 
and enables the analysis of thrombus aspirates. Methods: 
Consecutive patients undergoing primary PCI were enrolled 
from December 2009 to June 2011. Clinical, laboratory 
and angiographic data were prospectively collected and 
entered in a dedicated database. The decision to perform 
thromboaspiration was left to the discretion of the opera-
tors. One hundred and twelve samples of thrombi were 
collected, stored in 10% formalin-fixed paraffin, stained 
with hematoxylin-eosin and analyzed by light microscopy. 
On histopathological evaluation, the thrombi were classi-
fied as recent thrombi or lysed/organized thrombi. results: 
Recent thrombi were identified in 68 patients (61%) and 
lysed/organized thrombi in 44 patients (39%). Patients with 
recent thrombi had higher red blood cell infiltration (P = 
0.03). There were no other statistically significant differences 
identified for clinical, angiographic, laboratory or clinical 
outcomes between the two study groups. Conclusions: In 
patients with STEMI undergoing primary PCI, two-thirds 
of thrombus aspirates showed histopathological features 
of recent thrombi. There were no significant associations 
between these characteristics and clinical, laboratory and 
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Avaliação Histopatológica de Trombos Coronários 
em Pacientes com Infarto Agudo do Miocárdio  
e Elevação do Segmento ST
Introdução: A intervenção coronária percutânea (ICP) primária é 
o principal método de reperfusão em pacientes com infarto do 
miocárdio com supradesnivelamento do segmento ST (IAMCSST). 
A trombectomia por aspiração manual tem sido cada vez mais 
utilizada e possibilita a análise dos trombos aspirados. Métodos: 
Pacientes consecutivos submetidos a ICP primária foram incluí-
dos no período de dezembro de 2009 a junho de 2011. As 
características clínicas e laboratoriais e os dados angiográficos 
foram coletados prospectivamente e incluídos em banco de 
dados dedicado. A decisão de realizar tromboaspiração ficou a 
cargo dos operadores. Foram coletadas 112 amostras de trombos, 
armazenadas em formalina 10%, fixadas em parafina, coradas 
com hematoxilina-eosina, e analisadas por microscopia óptica. 
Na avaliação histopatológica, os trombos foram classificados 
em trombos recentes ou lisados/organizados. resultados: Foram 
identificados trombos recentes em 68 pacientes (61%) e trombos 
lisados/organizados em 44 pacientes (39%). Os pacientes com 
trombos recentes apresentaram maior infiltração de glóbulos 
vermelhos (P = 0,03). Não foram identificadas outras diferenças 
estatisticamente significantes em relação às características clínicas, 
angiográficas e laboratoriais ou aos desfechos clínicos entre os 
dois grupos estudados. Conclusões: Em pacientes com IAMCSST 
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angiographic data in this contemporary sample representa-
tive of the real world.
 
 
 
DESCrIPTorS: Myocardial infarction. Coronary thrombosis. 
Angioplasty.
submetidos a ICP primária, dois terços dos trombos aspirados 
apresentaram características histopatológicas de trombos recen-
tes. Não foram observadas associações significativas entre essas 
características e aspectos clínicos, laboratoriais e angiográficos 
nesta amostra contemporânea e representativa do mundo real.
DESCrITorES: Infarto do miocárdio. Trombose coronária. 
Angioplastia.
A cute ST-segment elevation myocardial infarction (STEMI) is a leading cause of death in Brazil. Manual aspiration thrombectomy is often used 
because it improves reperfusion and decreases mortality.1–6
In over 95% of cases, STEMI is related to a thrombus 
overlying an atherosclerotic plaque. Several studies have 
evaluated the characteristics of thrombi in patients with 
STEMI. The thrombi vary in size and colour, may be 
occlusive or non-occlusive, can spread in an antegrade 
or retrograde manner from the area of rupture, and 
often show different degrees of organization.
Studies have demonstrated an association among 
the histopathological characteristics, angioplasty results, 
and clinical outcomes of the thrombus.6–12 The avai l-
able analyses, however, are limited by the length of 
the inclusion of patients (since the year 2000) and the 
use of several different mechanical aspiration devices. 
These characteristics, together with changes in the 
pharmacological treatment and technical performance 
of primary percutaneous coronary intervention (PCI) in 
the last decade, may have influenced these findings.
This study evaluated the association between the 
histopathological characteristics of thrombus aspirates 
and the clinical data of patients undergoing primary 
PCI in the treatment of STEMI in contemporary clini-
cal practice.
Methods
study design and Patient Population
A prospective cohort study with clinical data 
collected in accordance with the STEMI protocol of 
a tertiary cardiology hospital began in December of 
2009. Thrombi collection occurred from April of 2010 
to June of 2011.
The study included consecutive patients treated at the 
emergency department of the Instituto de Cardiologia do 
Rio Grande do Sul, Brazil, diagnosed with STEMI, who 
wished to participate in the study, and who underwent 
thrombus collection during the primary PCI performed at 
the discretion of the physician responsible for the proce-
dure. Patients aged < 18 years were excluded.
The project was approved by the Ethics Commit-
tee in Research of the Instituto de Cardiologia do Rio 
Grande do Sul.
All patients were instructed about the study, and 
those who were enrolled signed an informed consent. 
Data collection was performed through paper forms 
prepared by the researchers involved in the study, and 
the data were stored in a dedicated database using 
Access software. Data entry was verified by a second 
researcher.
thrombus collection and histopathological 
analysis
The thrombi were collected, stored in formaldehyde 
and analysed by three pathologists blinded to their 
clinical characteristics. Among the devices used for 
aspiration were the Export (Medtronic Vascular Inc. – 
Santa Rosa, USA), Pronto (Vascular Solutions – Min-
neapolis, USA), Diver (Invatec – Brescia, Italy), and 
Thrombuster® (Kaneka Medix Corporation – Osaka, 
Japan) catheters. Blood collection was performed at 
the emergency department and was analysed by the 
laboratory of the Instituto de Cardiologia.
Immediately after thrombus aspiration, the filter 
device was placed in 10% formalin, aspirated, and 
fixed for 24 hours. The number of fragments from each 
aspirated thrombus was recorded. The sample was then 
embedded in paraffin, submitted to serial histological 
sections with a thickness of 8 microns, and stained with 
hematoxylin-eosin. In the histopathological analysis, the 
thrombi were classified into three groups according to the 
following previously reported criteria:3,12 recent thrombi 
(< one day) composed of patterns of layers of platelets, 
fibrin, red cells and granulocytes; thrombus lysates 
(one to five days), characterised by areas of apoptosis, 
necrosis and leukocytes; and organised thrombi (> five 
days), showing internal growth of smooth muscle cells 
and/or connective tissue deposition. The composition 
of a recent and a non-recent thrombus at the optical 
microscopy is shown in Figures 1 and 2, respectively. 
The thrombotic material was classified according to age. 
In each case, the number of leukocytes, erythrocytes, 
and fibrin in percentages is also described.
statistical analysis
The patients were divided into two groups accor-
ding to the histological age of the thrombus: recent and 
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lysate/organised. Quantitative variables were expressed as 
the means ± standard deviation or medians (interquartile 
range). Categorical variables were expressed as absolute 
and relative frequencies and analysed by chi-squared 
test or Fisher’s exact test. The significance was set at 
P < 0.05. The data were analysed using the Statistical 
Package for Social Sciences (SPSS) software, release 17.0.
Results
During the study period, 812 patients with STEMI 
were evaluated, of whom 255 (31.4%) underwent throm-
bus aspiration. The success rate was 70% (179/255), 
and information about the thrombi was available for 
analysis in 112 patients (62.5%). The flow chart of the 
study is shown in Figure 3.
Recent thrombi were identified in 68 patients (61%), 
and lysed/organised thrombi were found in 44 patients 
(39%). The angiographic and clinical laboratory results 
are shown in Table 1, and an associative trend was 
observed in the recent thrombus groups with a family 
history of coronary artery disease (P = 0.09) and with 
blush grade 3 pre-PCI (P = 0.08). In the group of pa-
tients with lysed/organised thrombi, an associative trend 
was observed with prior coronary artery bypass graft 
(P = 0.07) and with triple vessel coronary artery disease 
(P = 0.06). Regarding the laboratory characteristics, there 
were no statistically significant differences bet ween the 
groups. In relation to the medications used during the 
hospitalisation of both groups of patients, there was no 
statistically significant difference (Table 2).
Regarding the histopathological data, a greater 
erythrocyte infiltration was observed in patients with 
recent thrombi (P = 0.03). There were no statistically 
significant differences in the number of aspirated frag-
ments, size and volume of the thrombi, and infiltration 
of the leukocytes and fibrin (Table 3).
The major cardiovascular outcomes over the 30-
day follow-up are shown in Figure 4. There were no 
statistically significant differences, but patients with 
recent thrombi tended to have higher rates of post-
implant stent thrombosis.
discussion
In the present study, the histopathological findings 
of coronary thrombi in patients undergoing primary PCI 
for artery recanalisation related to STEMI are described, 
ERYTHROCYTES
FIBRIN
LEUKOCYTES
loose
connective
tissue
812 patients with STEMI
255 (31.4%) submitted
to thrombus aspiration
70% of success (179/255)
112 (62.5%) thrombi
available for analysis
Figure 1 – Composition of a fresh thrombus by optical microscopy, 
characterised by the presence of erythrocytes, leukocytes, and fibrin.
Figure 2 – Composition of a non-recent thrombus by optical microscopy, 
characterised by the formation of loose connective tissue.
Figure 3 – Study flow chart. STEMI = ST-segment elevation acute 
myocardial infarction.
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TAbLE 1 
Clinical, angiographic and laboratory characteristics
recent
(n = 68)
Non-recent
(n = 44) P
Age, years 56.8 ± 12.2 60.5 ± 12.9 0.13
Male gender, % 73 66 0.38
Hypertension, % 62 59 0.77
Diabetes mellitus, % 16 13 0.71
Dyslipidaemia, % 29 36 0.44
Smoking, % 47 43 0.39
Family history of coronary artery disease, % 35 20 0.09
Previous history, %
Percutaneous coronary intervention 15 14 0.87
Coronary artery bypass graft surgery 0 4.5 0.07
Myocardial infarction 21 15 0.48
Congestive heart failure 18 13 0.48
Chronic renal disease 1.5 4.5 0.32
Prior infarction, % 42 41 0.85
Delta T, hours 4.20 ± 2.78  4.10 ± 2.6 0.85
Door-to-balloon time, hours 1.46 ± 1.21 1.49 ± 1 0.89
Ischaemia time, hours 5.66 ± 3.1  5.59 ± 2.7 0.90
Three-vessel disease, % 3 16 0.06
Involvement of anterior descending artery, % 39 41 0.20
Vessel reference diameter, mm 3.42 ± 0.52  3.4 ± 0.56 0.81
Lesion extension, mm   19 ± 10.3 17.6 ± 7.08 0.46
TIMI Flow 3, %
Pre 8.8 4.5 0.43
Post 87 91 0.95
Blush 3, %
Pre 7.4 0 0.08
Post 63 60 0.82
TIMI score  2.94 ± 1.89  3.47 ± 1.96 0.18
Laboratory assessment
Glycaemia, mg/dL 174.58 ± 71.36 156.35 ± 58.58 0.17
Total cholesterol, mg/dL 204.59 ± 49.71 199.49 ± 49.03 0.61
HDL cholesterol, mg/dL  39.6 ± 11.9  41.4 ± 11.8 0.45
Triglycerides, mg/dL  180.30 ± 199.17  132.47 ± 120.71 0.13
C reactive protein, mg/dL  1.05 ± 2.75 0.68 ± 0.97 0.42
Fibrinogen, mg/dL       211.64 ± 58.2 195.24 ± 61.39 0.19
Haematocrit, % 41.5 ± 4.19 41.2 ± 3.51 0.73
Haemoglobin, g/dL 13.9 ± 1.38 13.8 ± 1.46 0.76
Leukocytes, mm³ 13,392 ± 4,878 14,018 ± 4,708 0.50
Platelets, mm³ 254,816 ± 70,241 248,500 ± 68,550 0.65
Creatinine, mg/dL 1.05 ± 0.37 0.96 ± 0.29 0.23
CK MB peak, ng/mL 42.7 ± 80.7 30.4 ± 37.6 0.28
Troponina peak US, ng/dL 1,440 ± 2,741 2,044 ± 3,670 0.46
CK MB = creatine-kinase MB fraction; HDL = high-density lipoprotein; TIMI = Thrombolisys In Myocardial Infarction.
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as well as their correlations with clinical and laboratory 
data, aspects related to treatment and clinical outcomes. 
Although the study predominantly included patients with a 
time of pain onset < 12 hours, old thrombi were identified 
in approximately one-third of the cases, demonstrating 
that the process of thrombosis may begin hours before 
the onset of symptoms and complete vessel occlusion, 
as had been previously reported in other studies.3,13–17 
Moreover, no statistically significant associations were 
identified among the histopathological characterizations 
of the thrombus age and outcomes, time of symptom 
onset or other clinical and angiographic variables. To the 
authors’ knowledge, this is the first study in Brazil to 
evaluate the histopathological characteristics of patients 
with STEMI undergoing primary PCI.
Previous studies have evaluated the associations 
between the age of thrombi through histopathological 
evaluation and clinical, laboratory, or angiographic 
findings.3,7,8 In a report on 959 patients with STEMI 
undergoing primary PCI, recent thrombi were present in 
60% of the cases, and lysed or arranged thrombi were 
present in 40%, which is consistent with the findings of 
the present study. The distal embolization in this study 
was the only clinical aspect that had a statistically sig-
nificant association with the presence of recent thrombi.13 
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Figure 4 – Cardiovascular outcomes within 30 days. AMI = acute 
myocardial infarction.
TAbLE 2 
Medications administered within the first 24 hours of hospital admission
recent
(n = 68)
Non-recent
(n = 44) P
Aspirin, % 97 98 0.84
Clopidogrel, %
300 mg 10 11 0.85
600 mg 88 89 0.94
Glycoprotein IIb/IIIa inhibitor, % 54 45 0.35
Heparin, % 100 97 0.40
Statin, % 88 81 0.31
Beta-blocker, % 76 72 0.60
Angiotensin-converting enzyme inhibitor, % 75 74 0.94
Nitrate, % 34 21 0.14
TAbLE 3 
Histopathological Characteristics
recent
(n = 68)
Non-recent
(n = 44) P
Number of fragments  3.7 ± 3.3 3.8 ± 3.2 0.80
Dimension, mm 0.53 ± 0.43 0.57 ± 0.35 0.61
Volume, µm³   19 ± 18.6 25.3 ± 24.3 0.12
Erythrocytes, % 36.5 ± 23.9 27.05 ± 22.66 0.03
Leukocytes, % 15.4 ± 10.2 18.2 ± 11.9 0.19
Fibrin, % 48.3 ± 22.0 54.9 ± 20.4 0.11
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In another report with 99 samples of thrombus aspirates, 
there were 31 cases of organized thrombi (16%), 70 
cases of lysed thrombi (35%), and 98 cases of recent 
thrombi (49%); the age of the thrombus was related to 
the patient’s age, male gender, and the extent of the 
lesion.3 In a study with electrocardiographic correlation, 
an association was demonstrated between the incomplete 
recovery of the ST-segment and the presence of old 
thrombi, and this electrocardiographic alteration was a 
strong predictor of long-term mortality, regardless of the 
histopathology of the thrombi aspirates.7 Finally, in an 
analysis with a long follow-up, there was an increase 
in mortality at four years in patients with old thrombi, 
compared to those with recent thrombi.13
While each study had a significant number of patients, 
the aforementioned studies are limited by the length of 
time that they included patients (since the year 2000) and 
the use of different mechanical aspiration devices. These 
characteristics might have influenced the results due to 
changes in pharmacological treatment and primary PCI 
techniques over the last decade. The use of mechani-
cal aspiration devices could alter the histopathological 
characteristics of the thrombi, thereby influencing these 
analyses when compared to those performed with manual 
aspiration devices. In the present study, no association 
was observed between the thrombus age according to 
the proposed histopathological classification and clinical, 
angiographic or laboratory data. Although the present 
study had a smaller population than that of the Dutch 
group studies, it used only manual aspiration, which is 
currently the most commonly used technique; further-
more, the present data were recently collected, through 
a method representative of the real world.
During the Thrombus Aspiration during Percutaneous 
coronary intervention in Acute myocardial infarction 
Study (TAPAS), the histopathological analysis confirmed 
successful aspiration in 73% of patients. These thrombi 
were predominantly composed of platelets (recent 
thrombi), which is common in patients with STEMI. 
In that study, platelet thrombi were mainly small or 
moderate in size, whereas erythrocyte-rich thrombi 
were of moderate to large size.16
The acute arterial occlusion that determines STEMI 
is one of the final events in the progression of athero-
sclerotic plaques before the rupture or erosion phases, 
and these morphological alterations can occur days 
to weeks before the symptoms.18,20 It is possible that 
the continued inflammatory activity in atheromatous 
plaques is closely related to the rate of formation or 
propagation of coronary thrombi. In the present study, 
no association was found between C-reactive protein, 
a validated marker of inflammatory activity, and the 
histopathological characteristics of the thrombi.
The length of the thrombus may be another impor-
tant factor in determining thrombotic burden. Matura-
tion occurs more rapidly at the end segments through 
the formation of granulation tissue, while the medial 
segments remain platelet- and fibrin-rich.1,12,21 The au-
thors reported that the largest dimension and greatest 
volume of samples evaluated were related to the age 
of the thrombus (P = 0.01 and P = 0.04, respectively). 
Kraemer et al.13 and Rittersma et al.3 reported that older 
thrombi were identified in 79 of 115 (69%) patients, 
as well as that women more often showed erosion and 
had a higher prevalence of non-recent thrombi (44 of 
50, 88%) that ruptured (35 of 65, 54%, P < 0.001).
conclusions
In patients with STEMI undergoing primary PCI, 
two-thirds of thrombus aspirates presented histopatho-
logical features consistent with recent thrombi. However, 
there were no significant associations between these 
characteristics and clinical, laboratory, or angiographic 
aspects in this contemporary, representative sample 
from the real world.
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